LHCGR
LHCGR is the cell-surface receptor for both luteinizing hormone and choriogonadotropin, signalling through G proteins that activate adenylate cyclase. It is also known as LHR, LCGR, LGR2 and ULG5, and belongs to the glycoprotein hormone receptor group of G protein-coupled receptors. Browse Assay Genie's current range of LHCGR research reagents below, or read on for the biology behind the target.
LHCGR (luteinizing hormone/choriogonadotropin receptor) is the receptor for lutropin-choriogonadotropic hormone. A single receptor therefore responds to both luteinizing hormone and choriogonadotropin. Its activity is mediated by G proteins, which in turn activate adenylate cyclase, linking hormone binding at the cell surface to intracellular signalling.
The protein is localised to the cell membrane. It belongs to the G protein-coupled receptor 1 family and, within it, to the FSH/LSH/TSH subfamily. HGNC places the LHCGR gene in the glycoprotein hormone receptors group. The UniProt protein name is lutropin-choriogonadotropic hormone receptor, and the gene is also known by the aliases LHR, LCGR, LGR2, ULG5 and HHG. The mouse and rat orthologs are both named Lhcgr.
The LHCGR gene is clinically important because mutations in it cause disorders of male secondary sexual character development. These include familial male precocious puberty (testotoxicosis), hypogonadotropic hypogonadism, Leydig cell adenoma with precocious puberty, and male pseudohermaphroditism with Leydig cell hypoplasia. HGNC lists a previous name for the gene, hypergonadotropic hypogonadism. This disease association makes LHCGR a frequent subject in studies of gonadotropin signalling and reproductive endocrinology.
LHCGR mediates the cellular response to luteinizing hormone and choriogonadotropin, making it central to studies of gonadotropin action.
The receptor couples to G proteins that activate adenylate cyclase, providing a model for glycoprotein hormone receptor signal transduction.
Mutations in LHCGR underlie familial male precocious puberty (testotoxicosis) and hypogonadotropic hypogonadism, so the gene is studied in pubertal development.
LHCGR variants cause Leydig cell hypoplasia and Leydig cell adenoma with precocious puberty, linking the receptor to Leydig cell research.
LHCGR is the receptor for both luteinizing hormone and choriogonadotropin. Its activity is mediated by G proteins that activate adenylate cyclase. It sits in the cell membrane and belongs to the G protein-coupled receptor 1 family, FSH/LSH/TSH subfamily.
The approved name is luteinizing hormone/choriogonadotropin receptor, and UniProt uses lutropin-choriogonadotropic hormone receptor. Aliases include LHR, LCGR, LGR2, ULG5 and HHG. HGNC also records a previous name, hypergonadotropic hypogonadism. Check the datasheet of any product for its validated reactivity.
Yes. Mutations in the LHCGR gene cause disorders of male secondary sexual character development, including familial male precocious puberty, hypogonadotropic hypogonadism, Leydig cell adenoma with precocious puberty and Leydig cell hypoplasia. Mouse and rat both have an ortholog named Lhcgr.
Other glycoprotein hormone receptors, gonadotropin ligands and reproductive endocrinology targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P22888; product specifications from Assay Genie datasheets.